Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Ribupatide

A Phase III Study Evaluating the Efficacy and Safety of HRS9531 Injection in Subjects With Obstructive Sleep Apnea (OSA) and Obesity

Fujian Shengdi Pharmaceutical Co · Phase 3 · Recruiting · Enrollment 140

NCT06974851

No selected arm has a reported week for this endpoint.

    A solid line connects the weeks the source reports.